A Multi-Center, Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study of Dimebon [dimebolin] in Subjects With Huntington's Disease.

Trial Profile

A Multi-Center, Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study of Dimebon [dimebolin] in Subjects With Huntington's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2015

At a glance

  • Drugs Latrepirdine (Primary)
  • Indications Huntington's disease
  • Focus Adverse reactions
  • Acronyms DIMOND
  • Sponsors Medivation
  • Most Recent Events

    • 01 Feb 2010 Results published in Archives of Neurology.
    • 14 Apr 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 24 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top